98 related articles for article (PubMed ID: 12475180)
21. Nuclear factor of activated T-cells 1 increases sensitivity of v-myb transformed monoblasts to all-trans retinoic acid.
Trčka F; Šmarda J; Knopfová L; Kuziaková K; Beneš P
Cell Signal; 2013 Jul; 25(7):1546-55. PubMed ID: 23571271
[TBL] [Abstract][Full Text] [Related]
22. Differential and antagonistic effects of v-Jun and c-Jun.
Gao M; Morgan I; Vogt PK
Cancer Res; 1996 Sep; 56(18):4229-35. PubMed ID: 8797597
[TBL] [Abstract][Full Text] [Related]
23. Silver electrode as a sensor for determination of zinc in cell cultivation medium.
Kizek R; Trnková L; Sevcíková S; Smarda J; Jelen F
Anal Biochem; 2002 Feb; 301(1):8-13. PubMed ID: 11811961
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid receptor alpha suppresses transformation by v-myb.
Smarda J; Sugarman J; Glass C; Lipsick J
Mol Cell Biol; 1995 May; 15(5):2474-81. PubMed ID: 7739532
[TBL] [Abstract][Full Text] [Related]
25. An ex vivo model to study v-Myb-induced leukemogenicity.
Dvorakova M; Kralova J; Karafiat V; Bartunek P; Dvorak M
Blood Cells Mol Dis; 2001; 27(2):437-45. PubMed ID: 11259166
[TBL] [Abstract][Full Text] [Related]
26. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
27. BM2L is a spontaneous leukemogenic variant of a non-leukemogenic v-myb-transformed myeloid cell line.
Bottazzi ME; Goodenow MM; Moscovici MG; Moscovici C
Oncogene; 1993 Mar; 8(3):731-6. PubMed ID: 8437856
[TBL] [Abstract][Full Text] [Related]
28. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
Bader AG; Hartl M; Bister K
Virology; 2000 Apr; 270(1):98-110. PubMed ID: 10772983
[TBL] [Abstract][Full Text] [Related]
29. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene.
Introna M; Golay J; Frampton J; Nakano T; Ness SA; Graf T
Cell; 1990 Dec; 63(6):1289-97. PubMed ID: 2261644
[TBL] [Abstract][Full Text] [Related]
30. Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.
Cohen SB; Waha A; Gelman IH; Vogt PK
Oncogene; 2001 Jan; 20(2):141-6. PubMed ID: 11313943
[TBL] [Abstract][Full Text] [Related]
31. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
Burk O; Worpenberg S; Haenig B; Klempnauer KH
EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
[TBL] [Abstract][Full Text] [Related]
32. Characterization of sarcoma cell lines from v-jun transgenic mice.
Marshall GM; Vanhamme L
Cancer Res; 1993 Feb; 53(3):622-6. PubMed ID: 8425197
[TBL] [Abstract][Full Text] [Related]
33. Nuclear translocation of viral Jun but not of cellular Jun is cell cycle dependent.
Chida K; Vogt PK
Proc Natl Acad Sci U S A; 1992 May; 89(10):4290-4. PubMed ID: 1584763
[TBL] [Abstract][Full Text] [Related]
34. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
35. Extension of the DNA binding consensus of the chicken c-Myb and v-Myb proteins.
Weston K
Nucleic Acids Res; 1992 Jun; 20(12):3043-9. PubMed ID: 1620600
[TBL] [Abstract][Full Text] [Related]
36. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
Kilbey A; Black EJ; Unlu M; Gillespie DA
Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782
[TBL] [Abstract][Full Text] [Related]
37. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
Hadman M; Loo M; Bos TJ
Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933
[TBL] [Abstract][Full Text] [Related]
38. A dual activation mechanism for Myb-responsive genes in myelomonocytic cells.
Yamkamon V; Ivanova O; Braas D; Chayka O; Patmasiriwat P; Klempnauer KH
Blood Cells Mol Dis; 2008; 40(2):219-26. PubMed ID: 17950008
[TBL] [Abstract][Full Text] [Related]
39. p53 arrests growth and induces differentiation of v-Myb-transformed monoblasts.
Navrátilová J; Horváth V; Kozubík A; Lojek A; Lipsick J; Smarda J
Differentiation; 2007 Sep; 75(7):592-604. PubMed ID: 17309603
[TBL] [Abstract][Full Text] [Related]
40. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase.
Wei W; Jin J; Schlisio S; Harper JW; Kaelin WG
Cancer Cell; 2005 Jul; 8(1):25-33. PubMed ID: 16023596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
